Concord Biotech IPO: Check issue details, latest GMP, price band, other key key things to know
Concord Biotech IPO Dates: Concord Biotech IPO opens on August 4 and will close on August 8. The finalisation of allotment is expected to take place on August 11, while refunds will be initiated on August 14. The shares will be credited to the Demat accounts of eligible investors on August 17.
IPO Price Band: The company has set the price band for the public issue at ₹705 to ₹741 per share. Also Read: Concord Biotech IPO: Jhunjhunwala-backed Concord IPO sets price band at ₹705-741 IPO Size: The company plans to raise anywhere between ₹1,498-1,551 crore from the IPO. At the upper end of the price band, the Concord Biotech IPO size is ₹1,551 crore.
The IPO values the company at around ₹7,752 crore. Issue Details: The Rekha Jhunjhunwala-backed Concord Biotech IPO consists of a pure offer-for-sale (OFS) of 2,09,25,652 equity shares by Helix Investment Holdings Pte Ltd. Lot Size: The Concord Biotech IPO lot size is 20 shares and the minimum investment amount required by investors is ₹14,820.
IPO Lead Managers: The book running lead manager for the issue are Kotak Mahindra Capital, Citigroup Global and Jefferies India IPO Registrar: Link Intime India Pvt Ltd is the registrar for Concord Biotech IPO. Key shareholders: Helix Investment Holdings Pte Ltd holds a 20% stake in the company. Helix Investment Holdings is backed by Quadria Capital Fund LP, an Asian private equity fund with a focus on healthcare.
Read more on livemint.com
